Brief: Kolon Corp 2017/2018 Financial Statements Are Subject To Change Depending On Audit Results
15/05/2019 08:33
May 15 (Reuters) - Kolon Corp 002020.KS Says:
* AUDITOR PLANS TO CONDUCT SECOND AUDIT OF FINANCIAL
STATEMENTS OF
KOLON LIFE SCIENCE 102940.KQ , KOLON TISSUEGENE 950160.KQ
* ITS 2017/2018 FINANCIAL STATEMENTS ARE SUBJECT TO CHANGE
DEPENDING ON AUDIT RESULTS
Source text for Eikon: https://bit.ly/2VlLGmh
Further company coverage: 002020.KS
((Reuters Messaging:
hayoung.choi.thomsonreuters.com@reuters.net))
Recent news on Kolon TissueGene
See all newsBrief: Kolon Tissuegene To Conduct Capital Increase Of 60 Billion Won For Operational Funds
Brief: Kolon Tissuegene Highlights Long-Term Safety Data And Potential U.S. FDA Pathway For Tg-C At Oarsi World Congress
Brief: Kolon Tissuegene To Conduct Capital Increase Of 44 Billion Won For Operational Funds
Brief: Kolon Tissuegene To Conduct Capital Increase Of 48 Billion Won For Operational Funds
Brief: Kolon Corp 2017/2018 Financial Statements Are Subject To Change Depending On Audit Results